More on ANRO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-15.4% Growth)
- Ratings (8.5 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Alto Neuroscience (NY:ANRO)
Delayed: 22.74 +0.95 (4.36%)
Prev. Close $21.79  
Open$22.50 
52 Wk High$ 
52 Wk Low$ 
Day High$23.51 
Day Low$21.76 
P/E N/A  
EPS$ 
Volume558,218 

Friends, Peers and Foes (?): LAZR, REPL, RXST, CERE, RAPP (more...)

Jun 17, 2026 06:50 AM H.C. Wainwright Reiterates Buy Rating on Alto Neuroscience (ANRO)
Jun 15, 2026 08:03 AM Alto Neuroscience cites study showing pramipexole reduces anhedonia
Jun 15, 2026 08:03 AM Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
May 29, 2026 04:17 PM Form 4 Alto Neuroscience, Inc. For: May 27 Filed by: Miller Andrew Craig
May 29, 2026 04:16 PM Form 3 Alto Neuroscience, Inc. For: May 27 Filed by: Miller Andrew Craig
May 28, 2026 08:18 AM Form 8-K Alto Neuroscience, Inc. For: May 27
May 28, 2026 08:03 AM Alto Neuroscience adds Karuna founder Miller to board
May 28, 2026 08:03 AM Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors
May 27, 2026 06:49 AM H.C. Wainwright Reiterates Buy Rating on Alto Neuroscience (ANRO)
May 22, 2026 05:57 AM Wolfe Research Starts Alto Neuroscience (ANRO) at Outperform
View All Articles

Entities mentioned with ANRO

View All Entities